OpSens, Inc.
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- Public, Subsidiary
- Established
- 2003-01-01
- Employees
- 293
- Market Cap
- -
- Website
- http://www.opsens.com
Clinical Trials
3
Active:0
Completed:1
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)Evaluation of ARi with OpSens SavvyWire
Terminated
- Conditions
- Aortic Valve Insufficiency
- First Posted Date
- 2024-03-06
- Last Posted Date
- 2025-03-30
- Lead Sponsor
- Opsens, Inc.
- Target Recruit Count
- 13
- Registration Number
- NCT06295068
- Locations
- 🇺🇸
AHS Morristown Medical Center, Morristown, New Jersey, United States
SAvvyWire™ EFficacy and SafEty in Transcatheter Aortic Valve Implantation Procedures (SAFE-TAVI)
Not Applicable
Completed
- Conditions
- Severe Aortic Stenosis
- First Posted Date
- 2022-08-08
- Last Posted Date
- 2023-04-12
- Lead Sponsor
- Opsens, Inc.
- Target Recruit Count
- 119
- Registration Number
- NCT05492383
- Locations
- 🇪🇸
Hospital Universitari Germans Trias i Pujol, Badalona, Spain
🇪🇸Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
🇪🇸Hospital Universitari Vall d'Hebron, Barcelona, Spain
OpSens PRIME CLASS
Terminated
- Conditions
- Aortic Stenosis
- First Posted Date
- 2021-10-07
- Last Posted Date
- 2023-04-27
- Lead Sponsor
- Opsens, Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT05070130
- Locations
- 🇪🇸
Hospital Universitari Germans Trias i Pujol, Badalona, Spain
🇪🇸Hospital Gregorio Maranon, Madrid, Spain
🇪🇸Hospital Virgen de la Victoria, Malaga, Spain
News
No news found